top of page

Generis Announces Virtual Generate Conference 2020 – Safety and Pharmacovigilance

Updated: Jul 5, 2021

The conference will feature a mixture of presentations from Generis and leaders in the field of Pharmacovigilance and Safety. Oliver Mende from Bayer Pharmaceuticals will be sharing his expertise, Jamie Portnoff from JMP Consulting LLC will be delivering a talk on the changing landscape with ‘It’s time to re-think the organizational structure of your PV team (in anticipation of major technology changes)’ and Venugopal Mallarapu from Cognizant will talk about ‘Driving transformation in Safety & PV through next generation platforms’. Alongside a demo of the Pharmacovigilance configuration on the CARA Life Sciences Platform from James Kelleher, CEO of Generis, and a presentation from Max Kelleher, COO of Generis, about ‘What is Safety? A Fresh Look with a Focus on Automations Such as PSMF Annexes,’ there will also be a discussion panel where all speaker will explain the changes they anticipate in the industry and how they see them taking shape in the near future.

The conference will be made up of short exciting 25-minute talks, they will be highly interactive and allow participants to ask questions, answer polls, talk to other attendees and access a bank of great resources. Register now to ensure you don’t miss out :

About Generis

Generis is a global leader in information management systems, specialising in proven solutions for regulated industries. Established in 1997 as a consultancy group, Generis has since grown and developed alongside its flagship product CARA. Our mission is to provide a system which is seamless and user-friendly; a dedicated team works hard to guarantee customer satisfaction. Currently counting over 470,000 users across numerous industries worldwide, including 8 of the 10 largest Life Science companies, the CARA Workspace and the CARA Life Sciences Platform offer solutions for different use cases from Quality and RIM, to Labelling and Marketing.

Find out more at:

Contact us at :

bottom of page